Recent evidence indicates that free amino acids are nutrients as well as acting as chemical transmitters within the gastrointestinal tract. Gut glutamate research is the most advanced among 20 amino acids. Free glutamate carries the umami taste sensation on the tongue and a visceral sensation in the gut, especially the stomach. In theˆeld of taste physiology, the physiological meaning of the glutamate-derived chemical sense, the umami taste, has been proposed to be a marker of protein intake. Experimental evidence in gut glutamate physiology strongly supports this hypothesis. Free glutamate is sensed by the abdominal vagus and regulates gastrointestinal functions such as secretion and emptying to accelerate protein digestion. Clinical application of glutamate has also just begun to treat gastrointestinal disorders such as dyspepsia, ulcer, dry mouth and functional dyspepsia. In this review, we introduce recent advances in gut glutamate research and consider the possible contribution of glutamate to health.
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AMINO ACID-SENSING RECEPTORS DISTRIB-UTED IN THE TASTE AND GUT ORGANS
During the past 20 years, a wide variety of amino acid-sensing receptors have been identiˆed to distribute in non-neuronal peripheral tissues beyond the brain. For example, neuronal glutamate receptors such as metabotropic glutamate type 1 (mGluR1) and type 4 (mGluR4) are expressed in the taste cells on the tongue 1 3) as well as mucosal cells in the stomach and duodenum 4, 5) . Sweet taste receptors (T1R2/T1R3) and umami taste receptors (T1R1/ T1R3) for sensing amino acids on the tongue have also been indicated to be distributed in the intestine. 6 10) The calcium-sensing receptor (CaSR), which was originally discovered as a blood calcium sensor in the kidney, can also be activated by amino acids. 11) CaSR was reported to distribute in the gastrointestinal tract, including in the oral cavity. 12) Professor Hans Br äauner-Osborne recently reported that the GPRC6A receptor could act as lysine and arginine sensors. 13) This receptor is widely distributed in the gut organs, but the expression of GPRC 6A on taste tissue has not been identiˆed.
ROLE OF TASTE AND VISCERAL INFORMA-TION IN NUTRIENT HOMEOSTASIS
The abdominal vagus is extensively distributed in the digestive tract from the esophagus to the upper gastrointestinal tract, and functions as the primary neuroanatomical substrate in the gut-brain axis to transmit meal-related signals in the gastrointestinal mucosa to the brain, which mediates neuronal gastrointestinal functions (e.g., food digestion, emptying and absorption) and conscious sensations (e.g., satiety, nausea, and discomfort) 14 16) . Nutritional information from the gastrointestinal tract aŠects the regulation of food digestion and nutrient absorption as well as eating behavior, eventually contributing to the formation of dietary habits. A more detailed knowledge of the physiological signiˆcance of the gut nutrient perception would contribute to the development of new medicines to treat medical problems which have recently attracted a lot of attention, such as obesity, functional dyspepsia and irritable bowel syndrome, because these problems can also be called``eating habit style-related diseases.'' Several lines of evidence suggest that visceral information mediated by vagal aŠerents play an important role in feeding behaviors. For example, rats fed an essential amino acid (lysine)-deˆcient diet showed appetite loss, lower growth and hypersensitivity to 
Fig. 1. Taste Preference and Body Nutrient Condition
A: EŠect of lysine deˆciency on taste preference in rats. Normal rats preferred umami (glutamate) and sweet (glycine) amino acids, but lysinedeˆcient rats also preferred the bitter (lysine) amino acid. Data is quoted from Tabuchi et al. 18) B: Relationship between protein intake and umami taste preference. Changes in taste preference for umami taste (150 mM monosodium glutamate; MSG), salty taste (150 mM NaCl) and sweet taste (500 mM Glycine) in rats fed with various contents of protein diets (0 20 ％). Data is quoted from Torii et al. 19) stressors. 17) In the normal diets, rats did not prefer the taste of lysine, due to its bitter taste. However, lysine-deˆcient rats showed a high preference for lysine solution because their palatability for it changed, due to the deˆciency ( Fig. 1(A) ). 18) Nerve recording studies of taste and vagal aŠerents showed that the lysine sensitivity of the taste aŠerents was not changed in rats who were lysine deˆcient but the sensitivity for vagal aŠerent sensitivity for lysine was dramatically increased up to one hundred times. 19) These researchers proposed the hypothesis that lysine deˆciency changed the vagal aŠerent sensitivity for lysine, leading rats to selectively drink lysine-containing solution via brain coordination of taste and visceral information.
Regarding the preference for glutamate, an animal experiment has shown that a preference for the umami taste derived glutamate is somehow linked to the body's requirement to metabolize ingested dietary protein ( Fig. 1(B) ). In this experiment, rats received a diet containing stepwise increasing doses of puriˆed egg protein for the indicated periods, and the preferences to three taste solutions (NaCl, glycine and glutamate) were determined. When the protein content in diet is restricted to deˆcient levels around 0 5 ％, rats favor a salty taste (NaCl solution) and sweet taste (glycine solution) rather than the umami taste (monosodium glutamate solution). However, as the protein content in the diet increases, the taste preference for these solutions gradually changes. Interestingly, at a 20％ protein diet, rats favor an umami solution rather than a NaCl solution or glycine solution. 20, 21) This palatable change is explained by the requirement of glutamate as triggering molecules for gastric protein digestion. Thus, some lines of evidence strongly suggest that taste and visceral amino acid gut amino acid sensing can change feeding behavior to regulate the nutrient intake and help the maintenance of the body amino acid homeostasis.
TASTE FUNCTIONS VIA ORAL GLUTAMATE SENSING
As previously described, the sense of taste is the chemical sense to intake essential nutrients, and the sense helps us to trigger oral digestion mastication with saliva as well as to prepare the gastric and pancreatic digestions via the cephalic phase response. 22) The sense of Umami taste occurs by the binding of glutamate to umami taste receptors expressed on the taste cells within taste buds on the tongue. Many candidate receptors for umami taste receptors have recently been revealed, such as G-protein coupled receptors (T1R1/T1R3 heterodimers, metabotropic glutamate 1 and 4 and their truncated receptors). 23) The sense of umami taste evokes a series of autonomic re‰exes related to food ingestion. First, umami taste stimulation induces salivation, as observed in the other four basic tastes. It was reported that the potency in salivation of parotid glands in healthy volunteers is in the order of sour＞umami＞salty＞ sweet＞bitter. 24) We studied the e‹cacy of the umami taste for inducing human whole saliva compared to that of the sour taste with healthy volunteers. The sour taste stimulation evoked a transient increase in salivation, but umami taste stimulation induced longlasting salivation of more than 10 min. Interestingly, the total amount of saliva for 10 min with the umami taste was signiˆcantly larger than with the sour. 25) In contrast, there is no human evidence on the cephalic phase response induced by the umami taste, but it is estimated in animal experiments that the cephalic phase response with the umami taste can induce a cephalic phase response to activate vagal eŠerent activities of the gastric, pancreatic and celiac branches, and increase gastric and pancreatic exocrine (gastric and pancreatic juice) and endocrine (insulin) secretions. 26, 27) 
GLUTAMATE SIGNALING IN THE GUT
Since Iggo et al. for theˆrst time measured the nerve activity of the vagal aŠerent pathway with electrophysiological recordings, 28) a variety of nutrients such as glucose, amino acids and fatty acids have been found to activate the vagus from the gut, and a chemical perception system for nutrients has been assumed in the gastrointestinal mucosa, the so called`g ut nutrient-sensing.'' For years, scientiˆc knowledge about the mechanism and physiological signiˆcance of gut nutrient-sensing has not been advanced. However, identiˆcation of a series of amino acid-sensing receptors expressed in the gut as well as on the tongue elucidates the contribution of these receptors to the gut nutrient-sensing. Given this, what are the vagal sensing proˆles for amino acids? I would like to introduce our recent research work. Niijimâ rst reported that the injection of glutamate solution into the stomach, duodenum and portal vein increased nerveˆrings of aŠerentˆbers of the gastric, celiac and hepato-portal vagal branches (Fig.  2(A) ). 29) He suggested that the chemical perception in those organs by the vagus may act as nutrient information to the brain. We also investigated the amino acid sensing proˆle by the vagus in the gastrointestinal tract.
The results are shown in Fig. 2(B) . In the duodenum, all 20 amino acids could modulate the aŠerent activities of the celiac aŠerents. Glycine suppressed and glutamate, aspartate and tryptophan stimulate the aŠerent activities. 30) However, in the stomach, glutamate alone clearly increased the gastric aŠerent activities. 31) This strongly suggests that the intestinal mucosa has a mechanism that can recognize all the individual amino acids formed during protein digestion, but the gastric mucosa has a unique mechanism that can detect only free glutamate contaminated in Fig. 3 . Neuronal Pathways of Gut Glutamate and Glucose Perceptions within Rat Brain fMRI image after intra-gastric administrations of glutamate and glucose. Almost all gastric glutamate-mediated signaling was diminished by the total vagotomy, but gastric glucose (120 mmol/l)-mediated signaling was not aŠected by the vagotomy. The data are from Tsurugizawa et al. 32) proteins because the gastric proteolytic enzyme cannot digest protein to each amino acid.
Using the fMRI technique, we revealed that brain nuclei linked to feeding behaviors and gut functions are activated in response to the application of glutamate into the stomach. 32 34) Intra-gastric administration of 1％ glutamate activated the brain nuclei including the dorsal vagal nucleus (DVN) and the nucleus of solitary tract (NTS), which is the output and input of the vagal nerve, and the insula cortex integrated with taste and visceral information. At the same time, each nucleus of the hypothalamus conveying feeding behavior and body temperature control was activated. Since the brain activation was diminished by cutting the vagus nerve, it was conrmed that most of the brain response induced by luminal glutamate was carried through the vagal aŠer-ent pathway (visceral sensation). On the other hand, intra-gastric application of another nutrient, glucose, brought the activation of some brain nucleus, but the activation was not aŠected by cutting the vagus nerve (Fig. 3) . Glucose-induced brain activation seems to be mediated by humoral factors (gut-pancreatic hormones). Interestingly, the brain mechanisms for gutnutrient sensing seem to vary depending on nutrients. We need to conduct further experiments to identify the brain-gut communication for individual nutrients.
What is the mechanism involved in the gastric glutamate sensing by the vagus? As an example of signal transduction cascade of gut amino acid-sensing, we examined gastric glutamate-sensing cascade within mucosa, using electrophysiological and pharmacological techniques (Fig. 4) . 35) Vagal aŠerent activation induced by luminal glutamate was abolished by the treatment with type 3 serotonin receptor inhibitor, granisetron, serotonin synthesis inhibitor, and pnitrophenylalanine (PCPA). This indicates that the glutamate response was mediated by serotonin. Moreover, the response was also abolished by the treatment with nitric oxidase inhibitor, L-NAME. In the case of gastric aŠerents, a NO donor, sodium nitroprusside, is known to activate the aŠerentˆbers via the serotonin/5-HT3 cascade. 36) Taking these results together, it is indicated that luminal glutamate stimulates the mucosal receptors (perhaps mGluRs or T1Rs), which in turn stimulates mucosal NO/5-HT secretion couplings, and activates the 5-HT3 receptors at the nerve endings of gastric vagal aŠerents. However, we need further study to clarify whether this cascade is a common pathway in mucosal amino acid sensing or not.
Other experiments support the possibility that mucosal serotonin is involved in the gastric glutamate sensing. 31) In Fig. 5 , the serotonin content within the gastric mucosa, and the contents of serotonin and its metabolite, 5-hydroxy acetic acid (5-HIAA) in the portal vein after 150 mmol/l glutamate was introduced into the stomach are shown. The data clearly indicate that the mucosal serotonin was increased but the blood serotonin never increased. 5-HT metabolites were increased in the portal vein. The mucosal serotonin might be mobilized and then metabolized within the mucosa to prevent the penetration of the bioactive substance, serotonin, directly into the bloodstream. In fact, gastric mucosa is known to have dense monoamine oxidases (MAOs). 37, 38) Mucosal serotonin might be cleared by the enzyme or blood platelet uptake. Zhu et al. reported that glucose-sensing in the duodenum also mediated mucosal serotonin. 39) To date, more than 90％ body serotonin is known to be localized within gastrointestinal mucosa, but its physiological role is unclear, despite involvement in emergency reactions such as vomiting and diarrhea. We think that the physiological role of gut mucosal serotonin is as a mediator of gut nutrient sensing. In Fig. 6 , we summarize the possible mechanism involved in the gastric glutamate sensing.
PHYSIOLOGICAL SIGNIFICANCE OF GLUTA-MATE-INDUCED VISCERAL INFORMATION
We showed that gastric glutamate signaling potentiates gastric exocrine secretion such as gastric acid, pepsinogen and gastric juice, using Pavlov pouch dogs. In this experiment, we examined the eŠect of free glutamate on gastric acid secretion when injected directly into the main stomach of Pavlov pouch dogs. 40, 41) We used an enteral liquid diet (Elental TM ) as a nutrient, which is mainly composed of a mixture of amino acids,ˆnal nutrients digested from protein.
Elental TM is composed of 17 amino acids (Ile, Leu, Lys, Met, Phe, Thr, Trp, Val, His, Arg, Ala, Asp, Gln, Gly, Pro, Ser, Tyr), vitamins, carbohydrates and micronutrients, and this amino acid diet com- 41) pletely lacks glutamic acid in its composition. As a result, injection of the amino acid diet (1 kcal/ml, 20 ml) into the main stomach could induce slight gastric secretion. Surprisingly, in the presence of the Elental TM diet, intra-gastric application of free glutamate induced powerful gastric secretion in a dosedependent manner (Fig. 7) . The intra-gastric administration of glutamate aqueous solution without Elental TM failed to induce the gastric acid secretion at all. Interestingly, the glutamate eŠect seemed to appear speciˆcally in the amino acid diet. Moreover, the gastric eŠects of glutamate markedly decreased by about 80％ after cutting the vagus nerve innervations to the stomach. 41) That is, it was revealed in the dog experiments that glutamate directly acts in the stomach and helps the digestion of dietary protein in the stomach through stimulating vagal nerve dependent gastric exocrine secretion.
There is evidence in humans of food digestion via gut glutamate signaling. Dr. Zai and his colleague discovered that the addition of free glutamate to a high protein diet improved delayed gastric emptying and post-ingestive abdominal unpleasantness such as a heavy stomach (Fig. 8(A) ). 42) With a breath test using stable isotope-labeled ( 13 C) sodium acetate, they studied the supplemental eŠects of free glutamate to a high protein liquid diet (a mixture of 50％ casein calcium and 50％ dextrin, 1 kcal/ml, 400 kcal) and a 100 ％ pure dextrin diet (1 kcal/ml, 400 kcal) on the human gastric emptying rate in 10 healthy adults. The addition of free glutamate (0.5％) to the pure 100％ dextrin diet failed to increase the gastric emptying rate, but the supplementation of free glutamate to the high protein diet signiˆcantly promoted the delayed gastric emptying. In the post-ingestive sensory evaluation study, free glutamate supplementation showed no eŠect on abdominal discomfort in young adults (between 20 39 years old), but in adults more than 40 years old, the post-ingestive abdominal discomfort such as a heavy stomach and fullness was much improved (Fig. 8(B) ). 43) This result might suggest that the addition of free glutamate to a protein-rich diet 
. EŠects of Glutamate on Human Gastric Emptying and Post-ingestive Abdominal Feelings
A: EŠects of glutamate supplementations to the protein-rich and pure dextrin liquid diets on the gastric emptying rates in healthy adult volunteers. Gastric emptying rate was measured by the breath test using a stable isotope ( 13 C labeled acetate). B: EŠect of glutamate supplementation to the protein-rich liquid diet on abdominal discomfort in healthy adult volunteers. Data are quoted. 42, 43) enhanced gastric secretion, improving gastric protein digestion and accelerating the gastric emptying, leading to improvement of post-ingestive abdominal unpleasantness.
Hospitalized elderly often have advanced gastric atrophy with a decreased appetite and protein digestion, which cause a low-protein nutritional status with a plasma albumin level below 3.6 g/dl (protein energy malnutrition: PEM). Based on the results measuring the free glutamate contents of typical hospital meals for the elderly, Toyama and Tomoe reported that the free glutamate intake of the hospitalized elderly was about half that of the average glutamate intake of healthy Japanese elderly. 44) Therefore, to conˆrm the beneˆts of free glutamate intake in the hospitalized elderly, they conducted a clinical study of glutamate fortiˆcation to hospital meals. They obtained evidence that free glutamate supplementation to the daily main dish (porridge) of about 2.7 g/day improved elderly QOL measures such as the level of consciousness and some nutritional parameters (numbers of peripheral circulating lymphocytes and plasma albumin levels). 44 46) POSSIBLE CLINICAL APPLICATION AS A TARGET OF GUT GLUTAMATE SIGNALING
Improvement in Enteral Nutrition
Somekawa et al. reported that glutamate supplementation to an enteral liquid diet could prevent diarrhea induced by tube feedings in rats (Fig. 9) . 47) Repetitive injection (bolus injection of 5 ml/every h) of puriˆed protein liquid diet through a gastric tube could induce diarrhea after 7 injections. 0.5％ free glutamate supplementation to this protein liquid diet could suppress the incidence of the diarrhea after the 7th repetitive injection. Moreover, taking advantage of glutamate use for a clinical diet, a clinical physician, Dr. Ohura, pointed out many beneˆts for nutritional management of enteral liquid diets containing 0.5％ monosodium glutamate, which can reduce the incidence of diarrhea and gastro-esophageal re‰ux. 48) To date, the physiological importance of taste substances such as free glutamate (umami taste) contained in natural foods has been ignored, since historically, enteral liquid diets have been developed with theˆrst priority of delivering simple puriˆed nutrients to patients. We now believe that free glutamate supplementation to enteral liquid diets can improve the digestion, absorp- Fig. 9 . Application of Glutamate for Improving Enteral Nutrition Therapy A: Incidence of diarrhea induced by repetitive feedings through gastric tube in the glutamate fortiˆed (G) and non-fortiˆed (C) liquid diets. B: EŠect of glutamate on total incidence of diarrhea (7 h). Data are modiˆed from Somekawa et al. 47) tion and utilization of the diets through initiating visceral glutamate information from the stomach to the brain. Dyspepsia Another report describing the possible contribution of free glutamate in protein digestion was reported from the Russian Academy of Sciences in 1992. 49) They studied the free glutamate fortiˆca-tion of hospital meals served to patients with chronic atrophic gastritis. Supplementation of about 2 3 grams of free glutamate per day for a month markedly improved basal acid output (BAO) and maximal acid output (MAO) and appetite in the hospitalized patients Functional Dyspepsia Functional dyspepsia (FD) was deˆned as a clinical syndrome characterized by chronic or recurrent symptoms centered in the upper abdomen, in the absence of underlying histochemical disturbances. 50) The symptoms complex includes epi-gastric pain, bloating, postprandial fullness, early satiety, nausea, vomiting, belching and anorexia. Recently, it was reported that postprandial symptoms, especially postprandial fullness, is the most severe symptom in patients reporting aggravation by a meal. 51) There are three main possible mechanisms related to gastric disorders 52) : 1) delayed gastric emptying, 2) impaired gastric accommodation to a meal, and 3) hypersensitivity to gastric distention. Delayed gastric emptying was initially considered to be the main etiology of symptoms in FD. Therefore, Kusano et al. proposed the therapeutic possibility of glutamate in the FD patients by increasing gastric emptying. Delayed gastric emptying is a focal point of debate about anorexia caused by dyspepsia, and prokinetic agents are often administered in Japan for symptom therapy. 53) Gastrointestinal Ulcer Luminal glutamate induced mucosal secretions. Focusing on this glutamate eŠect, Professor Takeuchi proposed the possibility of preventing and treating drug-induced gastrointestinal ulcers. He clearly showed that glutamate-supplemented foods could protect non-steroid anti-in‰ammatory drug (NSAID)-induced gastric and duodenal ulcers in rat models. 54) The protective eŠects of glutamate were observed in H. pylori infected-gastric ulcers in the gerbil. 55) Oral care Saliva is essential for the maintenance of oral mucosa circumstances as well as oral functions such as speech, mastication, swallowing and taste sensation. Patients who visited hospitals with complaints of oral dryness in many cases have hypo-saliva secretion. 56) These patients also suŠer from secondary symptoms such as di‹culty speaking and swallowing, masticatory disturbance, mucosal pain and taste disorder. The patients' symptoms were relieved following increased salivation. Saliva also contains anti-bacteria, anti-viral and anti-fugal substances (i.e., IgA, defensins, mucin), and tissue recovery factors such as epidermal and transforming growth factors. Sever hypo-salivation after stroke and cancer radio and chemotherapy induced oral mucosa injury and bacterial outgrowth, leading to oral pain and aspiratory pneumonia. Sasano et al. attempted to treat dry mouth using umami taste stimulation instead of drug therapy (muscarine agonists), because umami taste induces long-lasting salivation from large salivary glands as well as minor salivary glands. 57) 
